Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $26.9 million.

  • Lemaitre Vascular's Accumulated Expenses rose 1464.27% to $26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.9 million, marking a year-over-year increase of 1464.27%. This contributed to the annual value of $24.7 million for FY2024, which is 457.51% up from last year.
  • Per Lemaitre Vascular's latest filing, its Accumulated Expenses stood at $26.9 million for Q3 2025, which was up 1464.27% from $23.0 million recorded in Q2 2025.
  • Lemaitre Vascular's 5-year Accumulated Expenses high stood at $26.9 million for Q3 2025, and its period low was $12.9 million during Q1 2022.
  • In the last 5 years, Lemaitre Vascular's Accumulated Expenses had a median value of $19.9 million in 2025 and averaged $19.5 million.
  • As far as peak fluctuations go, Lemaitre Vascular's Accumulated Expenses crashed by 1007.31% in 2022, and later skyrocketed by 3639.88% in 2023.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Accumulated Expenses stood at $16.3 million in 2021, then rose by 22.26% to $20.0 million in 2022, then rose by 18.45% to $23.6 million in 2023, then rose by 4.58% to $24.7 million in 2024, then grew by 8.9% to $26.9 million in 2025.
  • Its Accumulated Expenses stands at $26.9 million for Q3 2025, versus $23.0 million for Q2 2025 and $19.9 million for Q1 2025.